Term ended Apr 7, 2025 · Low confidence
20-year base term ended Apr 7, 2025
Held by Abbott Laboratories
Filed Aug 10, 2011 as application 13/206,636 · Granted Aug 14, 2012
Base term, 20 years from filing
Today
Term ended Apr 7, 2025
2005
2026
Clock starts
Apr 7, 2005
Apr 7, 2005
Term ended
Apr 7, 2025
Apr 7, 2025
Granted
Aug 14, 2012
Aug 14, 2012
base term
after the term ends
fee events
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
None
Term adjustment
No prosecution delay on this record.
No effect
Terminal disclaimer
Resolved from the filed document, referencing US 7,850,916, to Apr 7, 2025. The term already ends on or before that date, so the cap shortened nothing.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
5
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term is its 20-year base term, with no adjustment for prosecution delay. A terminal disclaimer is resolved from the filed document, and it ends no earlier than this term, so it shortens nothing. All three maintenance fees were paid, so no fee lapse ended it. Confidence: Low. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Apr 7, 2005, when application PCT/US2005/011602, the earliest non-provisional in its chain, was filed (this one was filed Aug 10, 2011); a parent in its chain could not be resolved (the next row) | Apr 7, 2025 | High confidence |
| Continuity chain | A parent in the chain could not be resolved | dated from this application's own claim | Medium confidence |
| Patent term adjustment | None on file | no change | High confidence |
| Terminal disclaimer cap | Disclaimer resolved from the filed document (refs US 7,850,916) | resolves to Apr 7, 2025, no earlier than this term, so no change | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | term ended | High confidence |
| Further caveats on record | The record names parents not resolved: PCTUS2005011602, PCTUS2005011602 | Low confidence overall | Low confidence |
| Computed term end | The steps above, in order | Apr 7, 2025 | Low confidence |
This family
| US 7,850,916 | In force Sep 2027 | Sep 2027 |
| US 9,084,995 | Lapsed on the fee record Jul 2023 | Jul 2023 |
| US 8,241,572 | this patent Apr 2025 | Apr 2025 |
| US 10,578,602 | In force Nov 2026 | Nov 2026 |
4 of 5 applications in this family shown, earliest filings first. The applications whose file history this site holds. The family may have others.
Assignments
Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Aug 10, 2011 Reel 26726, frame 400 | Wardlaw, Stephen C. | Wardlaw Partners LP | Assignment of Assignor's Interest |
| Aug 10, 2011 Reel 26726, frame 454 | Wardlaw Partners LP | QDX, Inc. | Assignment of Assignor's Interest |
| Aug 10, 2011 Reel 26726, frame 545 | QDX, Inc. | Abbott Laboratories | Assignment of Assignor's Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
Terminal disclaimer
A terminal disclaimer resolved from the filed document, referencing US 7,850,916, ends no earlier than this term, so it caps nothing.
Citations
59
later US patents cite this one
That is top 25% of utility patents granted in 2012 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.